Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made over the past two years, SARSCoV-2 virus still continues to cause intolerable health and economical losses. Vaccines are considered the most effective way to prevent infectious diseases, which has been reaffirmed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tukhvatulin, Amir I., Gordeychuk, Ilya V., Dolzhikova, Inna V., Dzharullaeva, Alina S., Krasina, Marina E., Bayurova, Ekaterina O., Grousova, Daria M., Kovyrshina, Anna V., Kondrashova, Alla S., Avdoshina, Daria V., Gulyaev, Stanislav A., Gulyaeva, Tatiana V., Moroz, Andrey V., Illarionova, Viktoria V., Zorkov, Ilya D., Iliukhina, Anna A., Shelkov, Artem Y., Botikov, Andrei G., Erokhova, Alina S., Shcheblyakov, Dmitry V., Esmagambetov, Ilias B., Zubkova, Olga V., Tokarskaya, Elisaveta A., Savina, Daria M., Vereveyko, Yulia R., Ungur, Anastasiya S., Naroditsky, Boris S., Ishmukhametov, Aydar A., Logunov, Denis Y., Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518644/
https://www.ncbi.nlm.nih.gov/pubmed/36031930
http://dx.doi.org/10.1080/22221751.2022.2119169

Ejemplares similares

Ejemplares similares